You are here: vision-research.eu » News

News

Topcon announces US Launch of the Harmony Glaucoma Module

Topcon Healthcare announced it has launched its new Glaucoma Module feature for the Harmony Clinical Data Management Solution.

New therapeutic approach may help treat age-related macular degeneration effectively

Runt-related transcription factor 1 (RUNX1) has been linked to retinal neovascularization and the development of abnormal blood vessels, which result in vision loss in diabetic retinopathy. Now, scientists have found that RUNX1 inhibition presents a new therapeutic approach in the treatment of age-related macular degeneration (AMD), which is the leading cause of blindness in the elderly worldwide.

FCI Ophthalmics announces availability of LacriJet for Monocanalicular Nasolacrimal Intubation

FCI Ophthalmics announced the launch of the LacriJet in the United States. It is the first, self-retaining monocanalicular nasolacrimal intubation preloaded on a single use injector, according to FCI Ophthalmics.

VRmagic Eyesi Slit Lamp Fundoscopy Module Launched in the UK

VRmagic’s new Fundoscopy Module can be mounted to the Eyesi Slit Lamp simulator table to enable a lifelike interaction. It is supported by comprehensive software offering a wide selection of cases for retinal examination, which will be continuously extended, according to a company news release.

Doctors reverse jumping vision caused by light deprivation

Gradual exposure to light restored vision to a migraine sufferer who developed miner's nystagmus after an extended period of severe light deprivation, reports a team led by UCL experts.

How Europe's €100 billion science fund will shape 7 years of research

Horizon Europe, the world’s largest multinational research and innovation programme, has issued its first call for grant applications.

NeurOptics Launches Virtual Pupillometry Education Platform

NeurOptics has launched its Pupillometry Education Symposiums platform, which includes a series of both product and clinical-focused presentations that demonstrate the essential role pupillometry and the Neurological Pupil index (NPi) play in the assessment and screening of patients at risk of neurological injury.

Researchers identify 127 glaucoma genes in largest study of its kind

In the largest genome-wide association study of glaucoma comparing the genes of 34,179 people with the disease to 349,321 control subjects, an international consortium of researchers identified 44 new gene loci and confirmed 83 previously reported loci linked to glaucoma. Loci are considered "genetic street addresses," denoting a specific location on a gene.

Prof Andrew Dick reappointed as Director of IoO

Congratulations to Professor Andrew Dick for being reappointed as Director of UCL Institute of Ophthalmology for the next five years.

AI-supported test predicts eye disease three years before symptoms

A pioneering new eye test, developed by scientists at UCL in collaboration with the Western Eye Hospital, London, may predict wet AMD, a leading cause of severe sight loss, three years before symptoms develop.

Zika virus affects eye development before but not after birth

While the SARS-CoV-2 virus has dominated the news this past year, researchers continue to study the health effects of the Zika virus, which has been reported in 86 countries globally.

AI screening algorithms to diagnose diabetic retinopathy do not show consistent performance

Diabetes continues to be the leading cause of new cases of blindness among adults in the United States. But the current shortage of eye-care providers would make it impossible to keep up with demand to provide the requisite annual screenings for this population.

Aerie Pharmaceuticals Receives European Commission Approval for Glaucoma Treatment Roclanda

Aerie Pharmaceuticals announced the European Commission (EC) has granted a marketing authorization for Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% for the reduction of elevated IOP in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient IOP reduction.

Surgeons discuss how to address astigmatism during cataract surgery

Correcting astigmatism is an important part of cataract surgery, especially as the goals of modern cataract surgery have evolved to mirror that of refractive surgery, responding to heightened expectations of patients.

Beacon Bursaries awarded to IoO and Slade School of Fine Art joint project

IoO's Dr Emily Patterson and UCL Slade School of Fine Art's Jo Guile were selected in the latest round of the Beacon Bursary public engagement funding scheme.